📇 Rhumatologue · ST PIERRE · (974) · Hospitalier
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Plateau technique de référence
Centre hospitalier universitaire (CHU) — équipements et expertise pointus pour les cas complexes
Délais de RDV courts dans la région
119.7 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CHU SITE SUD (SAINT PIERRE)
AV FRANCOIS MITTERRAND BP 350 TERRE SAINTE, 97410 ST PIERRE
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Liver international : official journal of the International Association for the Study of the Liver · 2022
AbstractBackground & AimsThe boundary between non‐alcoholic (NAFLD) and alcohol‐related liver disease (ALD) is based on alcohol consumption. However, metabolic syndrome and alcohol use frequently co‐exist. The aim of this study was to determine prognostic factors of long‐term morbidity and mortality in patients with NAFLD or ALD.MethodsFrom 2003 to 2016, all consecutive NAFLD or ALD patients were prospectively included in this cohort study. We evaluated overall survival, specific cause of mortality and occurrence of any complication. The primary endpoint was analysed by the Kaplan Meier method, secondary endpoints were estimated by Gray test method or logistic regressions. Factors independently associated with overall mortality and morbidity were identified by a multivariate Cox model.ResultsA total of 3365 patients (1667 with ALD and 1698 with NAFLD) were included. Median follow‐up was 54 months (range: 30‐86) and 563 subjects died.In the overall population, overall mortality was higher in patients with ALD (HR: 10.1 [7.57‐13.3]), and with weekly alcohol consumption >7 units (HR:1.66 [1.41‐1.96]). Liver‐related mortality was higher in patients with ALD (HR: 11 [7.27‐16.5]). In the NAFLD group, weekly alcohol consumption >1 unit was associated with higher overall mortality (HR: 1.9 [1.1‐3.4]), and weekly alcohol consumption >7 units was associated with higher overall morbidity (OR: 1.89 [1.61‐2.21]). In the ALD group, the presence of metabolic syndrome was associated with higher overall (HR:1.27 [1.02‐1.57]), and liver (HR: 1.47 [1.1‐1.96]) mortalities, and overall (OR: 1.46 [1.14‐1.88]), liver (OR: 1.46 [1.14‐1.88]) morbidities.ConclusionIn fatty liver diseases, light alcohol consumption and metabolic syndrome are prognosis cofactors.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2020
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Liver international : official journal of the International Association for the Study of the Liver · 2022 · Journal Article
Decraecker M, Dutartre D, Hiriart JB, Irles-Depé M, et al.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2020 · Journal Article
Cassinotto C, Lapuyade B, Guiu B, Marraud des Grottes H, et al.